Respiratory infections Clinical Trials

12 recruitingLast updated: May 13, 2026

There are 12 actively recruiting respiratory infections clinical trials across 7 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Amiens, France, Augusta, Georgia, United States, Austin, Texas, United States. Updated daily from ClinicalTrials.gov.


Respiratory infections Trials at a Glance

12 actively recruiting trials for respiratory infections are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Amiens, Augusta, and Austin. Lead sponsors running respiratory infections studies include BioMérieux, Centre Hospitalier Emile Roux, and Assistance Publique - Hôpitaux de Paris.

Browse respiratory infections trials by phase

About Respiratory infections Clinical Trials

Looking for clinical trials for Respiratory infections? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Respiratory infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Respiratory infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Functional Impact of Acute Respiratory Viral Infections in Older Adults

Respiratory Infections in Old Age
University Hospital, Grenoble1,600 enrolled24 locationsNCT07388173
Recruiting
Not Applicable

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

Acute Respiratory Infections (ARIs)
BioMérieux800 enrolled2 locationsNCT07513519
Recruiting
Not Applicable

Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing

Respiratory infectionsAntibiotic
Assistance Publique - Hôpitaux de Paris2,000 enrolled1 locationNCT07243249
Recruiting

Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity

Respiratory infectionsCarrier State
Philip Polgreen160 enrolled1 locationNCT05474430
Recruiting
Phase 1Phase 2

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Pseudomonas aeruginosaCystic Fibrosis LungRespiratory Infections, Recurrent, Chronic
Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088
Recruiting

The Fever Clinic Acute Respiratory Cohort

Influenza Like-illnessCommunity-acquired PneumoniaFebrile Illnesses+2 more
Fudan University1,000 enrolled1 locationNCT07278700
Recruiting
Not Applicable

Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial

Acute Respiratory Infections
Centre Hospitalier Emile Roux1,200 enrolled12 locationsNCT06569160
Recruiting

FebriDx® Pediatric Validation Study

Acute Respiratory Infections (ARIs)
Lumos Diagnostics800 enrolled10 locationsNCT07211997
Recruiting

Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections

Severe Respiratory Infections
Hospices Civils de Lyon360 enrolled3 locationsNCT05536219
Recruiting

Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian Emergency Department with suspected COVID-19.

COVID-19InfectionAcute Respiratory Infections
Planet Innovation300 enrolled1 locationACTRN12620001029987
Recruiting

A Clinical Registry for Children presenting to Hospital with Respiratory Infections.

Acute Respiratory Infection/ Respiratory InfectionsInfectious Diseases
Telethon Kids Institute4,000 enrolled1 locationACTRN12619000903189
Recruiting

Online decision support system for consumer health

Uptake of influenza vaccination (annual seasonal or H1N1) over the respiratory infections season (i.e. winter season)
The HCF Health and Medical Research Foundation600 enrolled1 locationACTRN12610000386033